Breast cancer and the renin-angiotensin system (RAS): Therapeutic approaches and related metabolic diseases

This publication has 169 references indexed in Scilit:

• Past, present, and future of radiotherapy for the benefit of patients
  Nature Reviews Clinical Oncology, 2012
• Angiotensin II Type 1 Receptor (AT-1R) Expression Correlates with VEGF-A and VEGF-D Expression in Invasive Ductal Breast Cancer
  Pathology and Oncology Research, 2012
• The G-protein-coupled estrogen receptor GPER in health and disease
  Nature Reviews Endocrinology, 2011
• Bisphosphonates and pathologic complete response to taxane‐ and anthracycline‐based neoadjuvant chemotherapy in patients with breast cancer
  Cancer, 2011
• Definition and classification of cancer cachexia: an international consensus
  The Lancet Oncology, 2011
• Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
  Breast Cancer Research and Treatment, 2011
• The renin angiotensin system and the metabolic syndrome
  Physiology & Behavior, 2010
• AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
  Proceedings of the National Academy of Sciences, 2009
• Specificity in cancer immunotherapy
  Seminars in Immunology, 2008
• Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts
  Cancer Research, 2006